Anacor Pharmaceuticals, of Palo Alto, Calif., appointed Karl Beutner chief medical officer.
Antibe Therapeutics Inc., of Calgary, Alberta, appointed George Jackowski to its board.
Archemix Corp., of Cambridge, Mass., appointed Michael Kallelis vice president of manufacturing, and Lawrence Best to its board.
Arginox Pharmaceuticals, of Menlo Park, Calif., appointed Richard Brewer to its board.
ArQule Inc., of Woburn, Mass., appointed Michael Astrue to its board.
Arysta LifeScience Corp., of Tokyo, appointed Peter Cimmet head of business development.
Asterand, of Detroit, appointed Rebecca Caffrey business development manager.
Astralis Ltd., of Fairfield, N.J., appointed Gordon Schooley to its board.